The remaining target genes showed a protective trend in regulating SNHL risk, except for the lipoprotein lipase lipid-lowering variant, which exhibited a tendency towards risk, although none reached statistical significance (Fig. 2). This evidence concerns the gene LPL and sensorineural hearing loss disorder.